Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Merrimack Pharmaceuticals)"
Count: 29
Selected: 0
| NCT ID | Title |
|---|
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | ||
| NCT02785068 | Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer | ||
| NCT02538627 | Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib | ||
| NCT02399137 | A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer | ||
| NCT02213744 | MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients | ||
| NCT01774851 | A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach | ||
| NCT01733004 | A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors | ||
| NCT01520389 | Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment | ||
| NCT01494506 | Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer | ||
| NCT01451632 | A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers | ||
| NCT01447706 | A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers | ||
| NCT01447225 | Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors | ||
| NCT01421472 | A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer | ||
| NCT01304797 | Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer | ||
| NCT01304784 | A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer | ||
| NCT01209195 | A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers | ||
| NCT01151046 | Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer | ||
| NCT01097460 | MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer | ||
| NCT00994123 | A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT00911898 | A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers | ||
| NCT00734305 | Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment | ||
| NCT00458146 | A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis | ||
| NCT00444743 | Phase 2 Study of MM-093 to Treat Patients With Uveitis | ||
| NCT00147329 | Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis | ||
| NCT00105976 | Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) | ||
| NCT02640365 | A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer | ||
| NCT02387216 | A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC | ||
| NCT01436565 | A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers | ||
| NCT03119064 | BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma |
